ProMetic Life Sciences Inc (PLI):企業の財務・戦略的SWOT分析

GlobalDataが発行した調査報告書(DATA904C3062)
◆英語タイトル:ProMetic Life Sciences Inc (PLI) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C3062
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年8月
◆ページ数:60
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

ProMetic Life Sciences Inc (PLI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ProMetic Life Sciences Inc (ProMetic) is a biopharmaceutical company that focuses on bioseparations, plasma-derived therapeutics and small-molecule drug development. The company develop products for the treatment for fibrosis, anemia, autoimmune diseases, inflammation and nephropathies. The company develops drug candidates based on its two drug discovery platforms: small molecule therapeutics (PSMT) and plasma-derived therapeutics platforms. The company owns research and development facilities in the UK, the US and Canada and has manufacturing facilities in Canada and the Isle of Man. The company conducts business development activities in the US, Europe and Asia. ProMetic is headquartered in Laval, Quebec, Canada.

ProMetic Life Sciences Inc Key Recent Developments

Aug 14,2018: Prometic Life Sciences announces second quarter 2018 financial results
May 15,2018: Prometic Announces 2018 first quarter financial results
Apr 03,2018: Prometic Announces Appointment of Bruce Wendel as Chief Business Development Officer
Mar 28,2018: Prometic Reports its Q4-2017 and YE-2017 Financial Results and Provides Update on Activities
Feb 20,2018: Prometic Announces Realignment of its Clinical Program Priorities for 2018

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
ProMetic Life Sciences Inc – Key Facts 6
ProMetic Life Sciences Inc – Key Employees 7
ProMetic Life Sciences Inc – Key Employee Biographies 8
ProMetic Life Sciences Inc – Major Products and Services 9
ProMetic Life Sciences Inc – History 10
ProMetic Life Sciences Inc – Company Statement 12
ProMetic Life Sciences Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 – Company Analysis 17
Company Overview 17
ProMetic Life Sciences Inc – Business Description 18
Business Segment: Bioseparations segment 18
Overview 18
Performance 18
Business Segment: Plasma-derived therapeutics segment 18
Overview 18
Performance 18
Business Segment: Small molecule therapeutics segment 18
Overview 18
Performance 19
Business Segment: United Kingdom 19
Performance 19
Geographical Segment: Austria 19
Performance 19
Geographical Segment: Canada 19
Performance 19
Geographical Segment: China 19
Performance 19
Geographical Segment: Korea 19
Performance 19
Geographical Segment: Netherlands 19
Performance 19
Geographical Segment: Other countries 19
Performance 19
Geographical Segment: Switzerland 20
Performance 20
Geographical Segment: United States 20
Performance 20
R&D Overview 20
ProMetic Life Sciences Inc – SWOT Analysis 21
SWOT Analysis – Overview 21
ProMetic Life Sciences Inc – Strengths 21
ProMetic Life Sciences Inc – Weaknesses 22
ProMetic Life Sciences Inc – Opportunities 23
ProMetic Life Sciences Inc – Threats 24
ProMetic Life Sciences Inc – Key Competitors 25
Section 3 – Company Financial Ratios 26
Financial Ratios – Capital Market Ratios 26
Financial Ratios – Annual Ratios 27
Performance Chart 30
Financial Performance 30
Financial Ratios – Interim Ratios 31
Financial Ratios – Ratio Charts 32
Section 4 – Company’s Lifesciences Financial Deals and Alliances 33
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 34
ProMetic Life Sciences Inc, Recent Deals Summary 35
Section 5 – Company’s Recent Developments 36
Apr 03, 2018: Prometic Announces Appointment of Bruce Wendel as Chief Business Development Officer 36
Mar 28, 2018: Prometic Reports its Q4-2017 and YE-2017 Financial Results and Provides Update on Activities 37
Feb 20, 2018: Prometic Announces Realignment of its Clinical Program Priorities for 2018 42
Nov 13, 2017: Prometic Reports 2017 Third Quarter Highlights and Financial Results 44
Aug 14, 2017: Prometic Reports 2017 Second Quarter Highlights and Financial Results 46
May 15, 2017: Prometic Reports 2017 First Quarter Highlights and Financial Results 48
May 10, 2017: Prometic reports its 2017 annual and special meeting of shareholders highlights 50
Apr 07, 2017: Prometic Receives $9.5 Million Purchase Order From Multinational Client 52
Mar 30, 2017: Prometic Reports its 2016 Fourth Quarter and Year End Highlights and Financial Results 53
Section 6 – Appendix 56
Methodology 56
Ratio Definitions 56
About GlobalData 60
Contact Us 60
Disclaimer 60

List of Tables
ProMetic Life Sciences Inc, Key Facts 6
ProMetic Life Sciences Inc, Key Employees 7
ProMetic Life Sciences Inc, Key Employee Biographies 8
ProMetic Life Sciences Inc, Major Products and Services 9
ProMetic Life Sciences Inc, History 10
ProMetic Life Sciences Inc, Other Locations 15
ProMetic Life Sciences Inc, Subsidiaries 15
ProMetic Life Sciences Inc, Key Competitors 25
ProMetic Life Sciences Inc, Ratios based on current share price 26
ProMetic Life Sciences Inc, Annual Ratios 27
ProMetic Life Sciences Inc, Annual Ratios (Cont...1) 28
ProMetic Life Sciences Inc, Annual Ratios (Cont...2) 29
ProMetic Life Sciences Inc, Interim Ratios 31
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 34
ProMetic Life Sciences Inc, Recent Deals Summary 35
Currency Codes 56
Capital Market Ratios 56
Equity Ratios 57
Profitability Ratios 57
Cost Ratios 58
Liquidity Ratios 58
Leverage Ratios 59
Efficiency Ratios 59

List of Figures
ProMetic Life Sciences Inc, Performance Chart (2013 - 2017) 30
ProMetic Life Sciences Inc, Ratio Charts 32
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 34

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ProMetic Life Sciences Inc (PLI):企業の財務・戦略的SWOT分析(ProMetic Life Sciences Inc (PLI) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆